{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:41:49Z","timestamp":1790008909020,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.yexmp.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:00:34Z","timestamp":1555491634000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Acute myeloid leukemia with t(8;21)(q22;q22.1)\/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes"],"prefix":"10.1016","volume":"108","author":[{"given":"Wei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2019.04.009_bb0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Acute myeloid leukemia with recurrent genetic abnormalities","author":"Arber","year":"2017"},{"issue":"2","key":"10.1016\/j.yexmp.2019.04.009_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1040-8428(02)00003-3","article-title":"The role of a Runt domain transcription factor AML1\/RUNX1 in leukemogenesis and its clinical implications","volume":"45","author":"Asou","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.yexmp.2019.04.009_bb0015","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/leu.2008.61","article-title":"Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis","volume":"22","author":"Becker","year":"2008","journal-title":"Leukemia."},{"issue":"3","key":"10.1016\/j.yexmp.2019.04.009_bb0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jcp.2003.012864","article-title":"Acute myeloid leukaemia with t(8;21) associated with \"occult\" mastocytosis. Report of an unusual case and review of the literature","volume":"57","author":"Bernd","year":"2004","journal-title":"J. Clin. Pathol."},{"issue":"18","key":"10.1016\/j.yexmp.2019.04.009_bb0025","first-page":"4173","article-title":"Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype","volume":"58","author":"Bloomfield","year":"1998","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.yexmp.2019.04.009_bb0030","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1200\/JCO.1999.17.12.3767","article-title":"Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered","volume":"17","author":"Byrd","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2019.04.009_bb0035","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","article-title":"Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study","volume":"107","author":"Cairoli","year":"2006","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.yexmp.2019.04.009_bb0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias","volume":"121","author":"Care","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.yexmp.2019.04.009_bb0045","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2012.07.001","article-title":"Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis","volume":"36","author":"Cornet","year":"2012","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.yexmp.2019.04.009_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0377-4929.101761","article-title":"Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22)","volume":"55","author":"Gadage","year":"2012","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"4","key":"10.1016\/j.yexmp.2019.04.009_bb0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1999.01449.x","article-title":"c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia","volume":"105","author":"Gari","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2019.04.009_bb0060","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Mastocytosis","author":"Horny","year":"2017"},{"issue":"8","key":"10.1016\/j.yexmp.2019.04.009_bb0065","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1097\/MPH.0b013e3182329b80","article-title":"Myelomastocytic Leukemia with t(8;21) in a 3-year-old child","volume":"33","author":"Intzes","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.yexmp.2019.04.009_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1309\/AJCP1Q0YSXEAHNKK","article-title":"Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"140","author":"Johnson","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.yexmp.2019.04.009_bb0075","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","article-title":"KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor","volume":"105","author":"Kohl","year":"2005","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.yexmp.2019.04.009_bb0080","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.exphem.2007.08.016","article-title":"The origin of neoplastic mast cells in systemic mastocytosis with AML1\/ETO-positive acute myeloid leukemia","volume":"35","author":"Nagai","year":"2007","journal-title":"Exp. Hematol."},{"issue":"24","key":"10.1016\/j.yexmp.2019.04.009_bb0085","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study","volume":"24","author":"Paschka","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.yexmp.2019.04.009_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.yexmp.2019.04.009_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.leukres.2006.03.006","article-title":"Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone","volume":"31","author":"Pullarkat","year":"2007","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2019.04.009_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12308-009-0023-2","article-title":"Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia","volume":"2","author":"Pullarkat","year":"2009","journal-title":"J. Hematop."},{"issue":"11","key":"10.1016\/j.yexmp.2019.04.009_bb0105","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.leukres.2013.08.010","article-title":"Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1","volume":"37","author":"Pullarkat","year":"2013","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.yexmp.2019.04.009_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-018-0116-1","article-title":"Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)","volume":"8","author":"Qin","year":"2018","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.yexmp.2019.04.009_bb0115","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.yexmp.2019.04.009_bb0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and C-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yexmp.2019.04.009_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830380319","article-title":"Concurrent acute myeloid leukemia and systemic mastocytosis","volume":"38","author":"Wong","year":"1991","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.yexmp.2019.04.009_bb0130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations","volume":"116","author":"Yang","year":"2010","journal-title":"Blood."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019302199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019302199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:52:39Z","timestamp":1757991159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019302199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"alternative-id":["S0014480019302199"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.04.009","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute myeloid leukemia with t(8;21)(q22;q22.1)\/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}